Pharmacogenetics testing is a type of genetic testing that analyzes an individual's genetic makeup to determine how they may respond to certain medications. It involves studying the variations in genes that affect drug metabolism, efficacy, and potential side effects.

Pharmacogenetics testing can provide valuable information to healthcare professionals in determining the most effective and safe medications for a particular individual. By understanding an individual's genetic variations, doctors can tailor drug prescriptions to match their specific genetic profile, potentially improving treatment outcomes and reducing the risk of adverse drug reactions.

This type of testing is particularly useful in determining the appropriate dosage of medications, predicting the likelihood of adverse drug reactions, and identifying individuals who may be poor responders to certain drugs. It can also help avoid trial-and-error approaches to medication selection, allowing for more personalized and precise treatment plans.

Pharmacogenetics testing is commonly used in various medical fields, including psychiatry, cardiology, oncology, and pain management. It is especially beneficial for medications with a narrow therapeutic index, where small variations in drug metabolism can significantly impact treatment outcomes.

The global Pharmacogenetics Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Pharmacogenetics Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmacogenetics Testing.

Report Scope

The Pharmacogenetics Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmacogenetics Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pharmacogenetics Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Pharmacogenetics Testing Market Report

Report Metric	Details
Report Name	Pharmacogenetics Testing Market
CAGR	5%
Segment by Type	Dosage Selection Adverse Reaction Assessment
Segment by Application	Enterprise Government
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Genetworx, ARUP Laboratories, Labcorp, Invitae, Clinical Labs, Abomics, Gravity Diagnostics, Carolina Pharmacy, Kailos Genetics, Fulgent Genetics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmacogenetics Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pharmacogenetics Testing Market report?

Ans: The main players in the Pharmacogenetics Testing Market are Genetworx, ARUP Laboratories, Labcorp, Invitae, Clinical Labs, Abomics, Gravity Diagnostics, Carolina Pharmacy, Kailos Genetics, Fulgent Genetics

What are the Application segmentation covered in the Pharmacogenetics Testing Market report?

Ans: The Applications covered in the Pharmacogenetics Testing Market report are Enterprise, Government

What are the Type segmentation covered in the Pharmacogenetics Testing Market report?

Ans: The Types covered in the Pharmacogenetics Testing Market report are Dosage Selection, Adverse Reaction Assessment

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pharmacogenetics Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Dosage Selection

1.2.3 Adverse Reaction Assessment

1.3 Market by Application

1.3.1 Global Pharmacogenetics Testing Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Enterprise

1.3.3 Government

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pharmacogenetics Testing Market Perspective (2019-2030)

2.2 Pharmacogenetics Testing Growth Trends by Region

2.2.1 Global Pharmacogenetics Testing Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Pharmacogenetics Testing Historic Market Size by Region (2019-2024)

2.2.3 Pharmacogenetics Testing Forecasted Market Size by Region (2025-2030)

2.3 Pharmacogenetics Testing Market Dynamics

2.3.1 Pharmacogenetics Testing Industry Trends

2.3.2 Pharmacogenetics Testing Market Drivers

2.3.3 Pharmacogenetics Testing Market Challenges

2.3.4 Pharmacogenetics Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pharmacogenetics Testing Players by Revenue

3.1.1 Global Top Pharmacogenetics Testing Players by Revenue (2019-2024)

3.1.2 Global Pharmacogenetics Testing Revenue Market Share by Players (2019-2024)

3.2 Global Pharmacogenetics Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Pharmacogenetics Testing Revenue

3.4 Global Pharmacogenetics Testing Market Concentration Ratio

3.4.1 Global Pharmacogenetics Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pharmacogenetics Testing Revenue in 2023

3.5 Pharmacogenetics Testing Key Players Head office and Area Served

3.6 Key Players Pharmacogenetics Testing Product Solution and Service

3.7 Date of Enter into Pharmacogenetics Testing Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmacogenetics Testing Breakdown Data by Type

4.1 Global Pharmacogenetics Testing Historic Market Size by Type (2019-2024)

4.2 Global Pharmacogenetics Testing Forecasted Market Size by Type (2025-2030)

5 Pharmacogenetics Testing Breakdown Data by Application

5.1 Global Pharmacogenetics Testing Historic Market Size by Application (2019-2024)

5.2 Global Pharmacogenetics Testing Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Pharmacogenetics Testing Market Size (2019-2030)

6.2 North America Pharmacogenetics Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Pharmacogenetics Testing Market Size by Country (2019-2024)

6.4 North America Pharmacogenetics Testing Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Pharmacogenetics Testing Market Size (2019-2030)

7.2 Europe Pharmacogenetics Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Pharmacogenetics Testing Market Size by Country (2019-2024)

7.4 Europe Pharmacogenetics Testing Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Pharmacogenetics Testing Market Size (2019-2030)

8.2 Asia-Pacific Pharmacogenetics Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Pharmacogenetics Testing Market Size by Region (2019-2024)

8.4 Asia-Pacific Pharmacogenetics Testing Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Pharmacogenetics Testing Market Size (2019-2030)

9.2 Latin America Pharmacogenetics Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Pharmacogenetics Testing Market Size by Country (2019-2024)

9.4 Latin America Pharmacogenetics Testing Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pharmacogenetics Testing Market Size (2019-2030)

10.2 Middle East & Africa Pharmacogenetics Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Pharmacogenetics Testing Market Size by Country (2019-2024)

10.4 Middle East & Africa Pharmacogenetics Testing Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Genetworx

11.1.1 Genetworx Company Detail

11.1.2 Genetworx Business Overview

11.1.3 Genetworx Pharmacogenetics Testing Introduction

11.1.4 Genetworx Revenue in Pharmacogenetics Testing Business (2019-2024)

11.1.5 Genetworx Recent Development

11.2 ARUP Laboratories

11.2.1 ARUP Laboratories Company Detail

11.2.2 ARUP Laboratories Business Overview

11.2.3 ARUP Laboratories Pharmacogenetics Testing Introduction

11.2.4 ARUP Laboratories Revenue in Pharmacogenetics Testing Business (2019-2024)

11.2.5 ARUP Laboratories Recent Development

11.3 Labcorp

11.3.1 Labcorp Company Detail

11.3.2 Labcorp Business Overview

11.3.3 Labcorp Pharmacogenetics Testing Introduction

11.3.4 Labcorp Revenue in Pharmacogenetics Testing Business (2019-2024)

11.3.5 Labcorp Recent Development

11.4 Invitae

11.4.1 Invitae Company Detail

11.4.2 Invitae Business Overview

11.4.3 Invitae Pharmacogenetics Testing Introduction

11.4.4 Invitae Revenue in Pharmacogenetics Testing Business (2019-2024)

11.4.5 Invitae Recent Development

11.5 Clinical Labs

11.5.1 Clinical Labs Company Detail

11.5.2 Clinical Labs Business Overview

11.5.3 Clinical Labs Pharmacogenetics Testing Introduction

11.5.4 Clinical Labs Revenue in Pharmacogenetics Testing Business (2019-2024)

11.5.5 Clinical Labs Recent Development

11.6 Abomics

11.6.1 Abomics Company Detail

11.6.2 Abomics Business Overview

11.6.3 Abomics Pharmacogenetics Testing Introduction

11.6.4 Abomics Revenue in Pharmacogenetics Testing Business (2019-2024)

11.6.5 Abomics Recent Development

11.7 Gravity Diagnostics

11.7.1 Gravity Diagnostics Company Detail

11.7.2 Gravity Diagnostics Business Overview

11.7.3 Gravity Diagnostics Pharmacogenetics Testing Introduction

11.7.4 Gravity Diagnostics Revenue in Pharmacogenetics Testing Business (2019-2024)

11.7.5 Gravity Diagnostics Recent Development

11.8 Carolina Pharmacy

11.8.1 Carolina Pharmacy Company Detail

11.8.2 Carolina Pharmacy Business Overview

11.8.3 Carolina Pharmacy Pharmacogenetics Testing Introduction

11.8.4 Carolina Pharmacy Revenue in Pharmacogenetics Testing Business (2019-2024)

11.8.5 Carolina Pharmacy Recent Development

11.9 Kailos Genetics

11.9.1 Kailos Genetics Company Detail

11.9.2 Kailos Genetics Business Overview

11.9.3 Kailos Genetics Pharmacogenetics Testing Introduction

11.9.4 Kailos Genetics Revenue in Pharmacogenetics Testing Business (2019-2024)

11.9.5 Kailos Genetics Recent Development

11.10 Fulgent Genetics

11.10.1 Fulgent Genetics Company Detail

11.10.2 Fulgent Genetics Business Overview

11.10.3 Fulgent Genetics Pharmacogenetics Testing Introduction

11.10.4 Fulgent Genetics Revenue in Pharmacogenetics Testing Business (2019-2024)

11.10.5 Fulgent Genetics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Pharmacogenetics Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Dosage Selection

Table 3. Key Players of Adverse Reaction Assessment

Table 4. Global Pharmacogenetics Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Pharmacogenetics Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Pharmacogenetics Testing Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Pharmacogenetics Testing Market Share by Region (2019-2024)

Table 8. Global Pharmacogenetics Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Pharmacogenetics Testing Market Share by Region (2025-2030)

Table 10. Pharmacogenetics Testing Market Trends

Table 11. Pharmacogenetics Testing Market Drivers

Table 12. Pharmacogenetics Testing Market Challenges

Table 13. Pharmacogenetics Testing Market Restraints

Table 14. Global Pharmacogenetics Testing Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Pharmacogenetics Testing Market Share by Players (2019-2024)

Table 16. Global Top Pharmacogenetics Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacogenetics Testing as of 2023)

Table 17. Ranking of Global Top Pharmacogenetics Testing Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Pharmacogenetics Testing Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Pharmacogenetics Testing Product Solution and Service

Table 21. Date of Enter into Pharmacogenetics Testing Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Pharmacogenetics Testing Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Pharmacogenetics Testing Revenue Market Share by Type (2019-2024)

Table 25. Global Pharmacogenetics Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Pharmacogenetics Testing Revenue Market Share by Type (2025-2030)

Table 27. Global Pharmacogenetics Testing Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Pharmacogenetics Testing Revenue Market Share by Application (2019-2024)

Table 29. Global Pharmacogenetics Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Pharmacogenetics Testing Revenue Market Share by Application (2025-2030)

Table 31. North America Pharmacogenetics Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Pharmacogenetics Testing Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Pharmacogenetics Testing Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Pharmacogenetics Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Pharmacogenetics Testing Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Pharmacogenetics Testing Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Pharmacogenetics Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Pharmacogenetics Testing Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Pharmacogenetics Testing Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Pharmacogenetics Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Pharmacogenetics Testing Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Pharmacogenetics Testing Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Pharmacogenetics Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Pharmacogenetics Testing Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Pharmacogenetics Testing Market Size by Country (2025-2030) & (US$ Million)

Table 46. Genetworx Company Detail

Table 47. Genetworx Business Overview

Table 48. Genetworx Pharmacogenetics Testing Product

Table 49. Genetworx Revenue in Pharmacogenetics Testing Business (2019-2024) & (US$ Million)

Table 50. Genetworx Recent Development

Table 51. ARUP Laboratories Company Detail

Table 52. ARUP Laboratories Business Overview

Table 53. ARUP Laboratories Pharmacogenetics Testing Product

Table 54. ARUP Laboratories Revenue in Pharmacogenetics Testing Business (2019-2024) & (US$ Million)

Table 55. ARUP Laboratories Recent Development

Table 56. Labcorp Company Detail

Table 57. Labcorp Business Overview

Table 58. Labcorp Pharmacogenetics Testing Product

Table 59. Labcorp Revenue in Pharmacogenetics Testing Business (2019-2024) & (US$ Million)

Table 60. Labcorp Recent Development

Table 61. Invitae Company Detail

Table 62. Invitae Business Overview

Table 63. Invitae Pharmacogenetics Testing Product

Table 64. Invitae Revenue in Pharmacogenetics Testing Business (2019-2024) & (US$ Million)

Table 65. Invitae Recent Development

Table 66. Clinical Labs Company Detail

Table 67. Clinical Labs Business Overview

Table 68. Clinical Labs Pharmacogenetics Testing Product

Table 69. Clinical Labs Revenue in Pharmacogenetics Testing Business (2019-2024) & (US$ Million)

Table 70. Clinical Labs Recent Development

Table 71. Abomics Company Detail

Table 72. Abomics Business Overview

Table 73. Abomics Pharmacogenetics Testing Product

Table 74. Abomics Revenue in Pharmacogenetics Testing Business (2019-2024) & (US$ Million)

Table 75. Abomics Recent Development

Table 76. Gravity Diagnostics Company Detail

Table 77. Gravity Diagnostics Business Overview

Table 78. Gravity Diagnostics Pharmacogenetics Testing Product

Table 79. Gravity Diagnostics Revenue in Pharmacogenetics Testing Business (2019-2024) & (US$ Million)

Table 80. Gravity Diagnostics Recent Development

Table 81. Carolina Pharmacy Company Detail

Table 82. Carolina Pharmacy Business Overview

Table 83. Carolina Pharmacy Pharmacogenetics Testing Product

Table 84. Carolina Pharmacy Revenue in Pharmacogenetics Testing Business (2019-2024) & (US$ Million)

Table 85. Carolina Pharmacy Recent Development

Table 86. Kailos Genetics Company Detail

Table 87. Kailos Genetics Business Overview

Table 88. Kailos Genetics Pharmacogenetics Testing Product

Table 89. Kailos Genetics Revenue in Pharmacogenetics Testing Business (2019-2024) & (US$ Million)

Table 90. Kailos Genetics Recent Development

Table 91. Fulgent Genetics Company Detail

Table 92. Fulgent Genetics Business Overview

Table 93. Fulgent Genetics Pharmacogenetics Testing Product

Table 94. Fulgent Genetics Revenue in Pharmacogenetics Testing Business (2019-2024) & (US$ Million)

Table 95. Fulgent Genetics Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Pharmacogenetics Testing Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Pharmacogenetics Testing Market Share by Type: 2023 VS 2030

Figure 3. Dosage Selection Features

Figure 4. Adverse Reaction Assessment Features

Figure 5. Global Pharmacogenetics Testing Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Pharmacogenetics Testing Market Share by Application: 2023 VS 2030

Figure 7. Enterprise Case Studies

Figure 8. Government Case Studies

Figure 9. Pharmacogenetics Testing Report Years Considered

Figure 10. Global Pharmacogenetics Testing Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 11. Global Pharmacogenetics Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Pharmacogenetics Testing Market Share by Region: 2023 VS 2030

Figure 13. Global Pharmacogenetics Testing Market Share by Players in 2023

Figure 14. Global Top Pharmacogenetics Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacogenetics Testing as of 2023)

Figure 15. The Top 10 and 5 Players Market Share by Pharmacogenetics Testing Revenue in 2023

Figure 16. North America Pharmacogenetics Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 17. North America Pharmacogenetics Testing Market Share by Country (2019-2030)

Figure 18. United States Pharmacogenetics Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. Canada Pharmacogenetics Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Europe Pharmacogenetics Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Pharmacogenetics Testing Market Share by Country (2019-2030)

Figure 22. Germany Pharmacogenetics Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. France Pharmacogenetics Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. U.K. Pharmacogenetics Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Italy Pharmacogenetics Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Russia Pharmacogenetics Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Nordic Countries Pharmacogenetics Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Asia-Pacific Pharmacogenetics Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Pharmacogenetics Testing Market Share by Region (2019-2030)

Figure 30. China Pharmacogenetics Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Japan Pharmacogenetics Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. South Korea Pharmacogenetics Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Southeast Asia Pharmacogenetics Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. India Pharmacogenetics Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Australia Pharmacogenetics Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Latin America Pharmacogenetics Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Pharmacogenetics Testing Market Share by Country (2019-2030)

Figure 38. Mexico Pharmacogenetics Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Brazil Pharmacogenetics Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Middle East & Africa Pharmacogenetics Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Pharmacogenetics Testing Market Share by Country (2019-2030)

Figure 42. Turkey Pharmacogenetics Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Saudi Arabia Pharmacogenetics Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Genetworx Revenue Growth Rate in Pharmacogenetics Testing Business (2019-2024)

Figure 45. ARUP Laboratories Revenue Growth Rate in Pharmacogenetics Testing Business (2019-2024)

Figure 46. Labcorp Revenue Growth Rate in Pharmacogenetics Testing Business (2019-2024)

Figure 47. Invitae Revenue Growth Rate in Pharmacogenetics Testing Business (2019-2024)

Figure 48. Clinical Labs Revenue Growth Rate in Pharmacogenetics Testing Business (2019-2024)

Figure 49. Abomics Revenue Growth Rate in Pharmacogenetics Testing Business (2019-2024)

Figure 50. Gravity Diagnostics Revenue Growth Rate in Pharmacogenetics Testing Business (2019-2024)

Figure 51. Carolina Pharmacy Revenue Growth Rate in Pharmacogenetics Testing Business (2019-2024)

Figure 52. Kailos Genetics Revenue Growth Rate in Pharmacogenetics Testing Business (2019-2024)

Figure 53. Fulgent Genetics Revenue Growth Rate in Pharmacogenetics Testing Business (2019-2024)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Portable Laboratory Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-18E11279

Thu Jun 20 00:00:00 UTC 2024

Add to Cart

Global Self-Standing Cryogenic Vials Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-25N13032

Thu Jun 20 00:00:00 UTC 2024

Add to Cart

Global Hybridization System Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-10O11293

Thu Jun 20 00:00:00 UTC 2024

Add to Cart

Global Deep Foundation Engineering Service Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-8G15386

Thu Jun 20 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions